Clinical trial
A Comparative Study of the Efficacy and Safety of Etomidate Compared to Propofol in Gastric Endoscopic Submucosal Dissection: a Prospective, Single-center, Randomized, Double-blind, Non-inferiority Study
NCT05407870 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative Study of the Efficacy and Safety of Etomidate Compared to Propofol in Gastric Endoscopic Submucosal Dissection: a Prospective, Single-center, Randomized, Double-blind, Non-inferiority Study
- Lead sponsor
- Korea University Anam Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 9, 2022
- Completion date
- November 24, 2022
- Enrollment
- 138 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endoscopic submucosal dissection, esophagogastroduodenoscopy, sedation complication